Patents by Inventor Edwin Harry Paterson Young

Edwin Harry Paterson Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4029786
    Abstract: The disclosure relates to new 2-(substituted anilino)methylmorpholine derivatives which possess antidepressant activity, to processes for the manufacture of the said morpholine derivatives and to pharmaceutical compositions containing them. Typical of the morpholine derivatives disclosed is 2-(2-ethoxyanilino)methylmorpholine.
    Type: Grant
    Filed: June 1, 1976
    Date of Patent: June 14, 1977
    Assignee: Imperial Chemical Industries Limited
    Inventor: Edwin Harry Paterson Young
  • Patent number: 4001418
    Abstract: The disclosure relates to thioxanthene derivatives which possess analgesic activity, to processes for the manufacture of said derivatives and to pharmaceutical compositions containing them. Typical of the thioxanthene derivatives disclosed is 4-acetoxy-6-chloro-1'-methylthioxanthene-9-spiro-4'-piperidine.
    Type: Grant
    Filed: January 9, 1975
    Date of Patent: January 4, 1977
    Assignee: Imperial Chemical Industries Limited
    Inventors: Ronald Hilson Begg Galt, Edwin Harry Paterson Young
  • Patent number: 3974158
    Abstract: The disclosure relates to new 2-(substituted anilino)methylmorpholine derivatives which possess antidepressant activity, to processes for the manufacture of the said morpholine derivatives and to pharmaceutical compositions containing them. Typical of the morpholine derivatives disclosed is 2-(2-ethoxyanilino)methylmorpholine.
    Type: Grant
    Filed: August 10, 1973
    Date of Patent: August 10, 1976
    Assignee: Imperial Chemical Industries Limited
    Inventor: Edwin Harry Paterson Young
  • Patent number: 3974156
    Abstract: The disclosure relates to new 2-(substituted anilino)-methylmorpholine derivatives which possess sedative activity, to processes for the manufacture of the said morpholine derivatives, and to pharmaceutical compositions containing them. Typical of the morpholine derivatives disclosed is 2-(3-methoxyanilino)methylmorpholine.
    Type: Grant
    Filed: August 10, 1973
    Date of Patent: August 10, 1976
    Assignee: Imperial Chemical Industries Limited
    Inventor: Edwin Harry Paterson Young